April 22, 2020
A poor diagnosis leads to poor outcomes. But not with Nocimed, a cloud-based SaaS provider of adjunctive diagnostics for chronic low back pain. The company, based in San Mateo, California, is expanding after beginning 2020 in 10 markets between the US and Europe. Nocimed was founded on the premise that when it comes to low back pain diagnosis and related patient management, there has to be a better way.
Our mission is simple: help doctors obtain a better diagnosis and help patients get information sooner on what might be causing their chronic low back pain.
With Nocimed, a 3D area of the disc is “captured” on an MRI. This is then “vibrated” by an MR scanner using a NOCISCAN-LS exam protocol utilizing existing magnetic resonance spectroscopy pulse sequences that are optimized for the specific application to discs. This way, physicians and radiologists receive data that identify degeneration and pain between discs in the lumbar spine. This information will help physicians determine which specific discs require treatment.
NOCISCAN Suite published clinical trial results show improved outcomes for patients who received treatment at the discs identified with the highest relative scores for degenerative painful disc chemicals.
Nocimed is seeking qualified US and OUS distributors with experience in the pain management or spine industry. Please contact Nocimed at email@example.com.
If your organization is interested in partnering with Nocimed to overhaul the paradigm in spinal diagnostics, please contact them directly at firstname.lastname@example.org.
For more information, please visit www.nocimed.com.